MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):667-673. doi: 10.15585/mmwr.mm7018a2.
When the Global Polio Eradication Initiative (GPEI) was established in 1988, an estimated 350,000 poliomyelitis cases were reported worldwide. In 2020, 140 wild poliovirus (WPV) cases were confirmed, representing a 99.99% reduction since 1988. WPV type 1 transmission remains endemic in only two countries (Pakistan and Afghanistan), but outbreaks of circulating vaccine-derived poliovirus (cVDPV) occurred in 33 countries during 2019-2020 (1,2). Poliovirus transmission is detected primarily through syndromic surveillance for acute flaccid paralysis (AFP) among children aged <15 years, with confirmation by laboratory testing of stool specimens. Environmental surveillance supplements AFP surveillance and plays an increasingly important role in detecting poliovirus transmission. Within 2 weeks of COVID-19 being declared a global pandemic (3), GPEI recommended continuing surveillance activities with caution and paused all polio supplementary immunization activities (4). This report summarizes surveillance performance indicators for 2019 and 2020 in 42 priority countries at high risk for poliovirus transmission and updates previous reports (5). In 2020, 48% of priority countries* in the African Region, 90% in the Eastern Mediterranean Region, and 40% in other regions met AFP surveillance performance indicators nationally. The number of priority countries rose from 40 in 2019 to 42 in 2020. Analysis of 2019-2020 AFP surveillance data from 42 countries at high risk for poliovirus transmission indicates that national and subnational nonpolio AFP rates and stool specimen adequacy declined in many priority countries, particularly in the African Region, suggesting a decline in surveillance sensitivity and quality. The findings in this report can be used to guide improvements to restore a sensitive surveillance system that can track poliovirus transmission and provide evidence of interruption of transmission.
当全球根除脊髓灰质炎倡议(GPEI)于 1988 年成立时,全球估计有 35 万例脊髓灰质炎病例报告。2020 年,确认了 140 例野生脊髓灰质炎病毒(WPV)病例,自 1988 年以来减少了 99.99%。WPV 1 型传播仍然局限于两个国家(巴基斯坦和阿富汗),但在 2019-2020 年期间,有 33 个国家发生了循环疫苗衍生脊髓灰质炎病毒(cVDPV)疫情(1,2)。脊髓灰质炎病毒的传播主要通过对<15 岁儿童的急性弛缓性麻痹(AFP)进行综合征监测来发现,并通过对粪便标本的实验室检测来确认。环境监测补充了 AFP 监测,在发现脊髓灰质炎病毒传播方面发挥着越来越重要的作用。在宣布 COVID-19 为全球大流行(3)后两周内,GPEI 建议谨慎继续监测活动,并暂停所有脊髓灰质炎补充免疫活动(4)。本报告总结了 2019 年和 2020 年在高传播风险的 42 个优先国家的监测表现指标,并更新了以往的报告(5)。2020 年,非洲区域 48%的优先国家*、东地中海区域 90%的优先国家和其他区域 40%的优先国家在国家一级达到了 AFP 监测表现指标。优先国家的数量从 2019 年的 40 个增加到 2020 年的 42 个。对高传播风险的 42 个国家的 2019-2020 年 AFP 监测数据的分析表明,许多优先国家,特别是非洲区域的国家,国家级和国家级以下非脊髓灰质炎 AFP 发病率和粪便标本充足性下降,表明监测敏感性和质量下降。本报告中的发现可用于指导改进措施,以恢复能够跟踪脊髓灰质炎病毒传播并提供传播中断证据的敏感监测系统。